Cost-Effectiveness of Ceftolozane/Tazobactam as Empiric Therapy for the Treatment of Complicated Urinary Tract Infections in Colombia
Abstract
Authors
P Lasalvia D Rosselli C Castañeda-Cardona J Garzon F Hernández C Beltran M Rojas MC Lopez EM Sarpong